Medical News and Perspectives |

Cardiovascular Death Risk Linked to Azithromycin Use

Bridget M. Kuehn
JAMA. 2012;307(22):2361. doi:10.1001/jama.2012.6421.
Text Size: A A A
Published online


Patients taking a 5-day course of the widely used drug azithromycin, commonly known as the “Z-Pak,” are at increased risk of death, according to a Food and Drug Administration (FDA) alert issued in mid May.

The alert was prompted by the publication of a study that found a small increased risk of cardiovascular death during the course of therapy with azithromycin (Ray WA et al. N Engl J Med. 2012;366[20]:1881-1890). The researchers compared short-term cardiac death rates among 3 groups: 347 795 individuals enrolled in Tennessee Medicaid who received prescriptions for azithromycin, more than 1 million propensity-matched controls not taking an antibiotic, and more than 1 million individuals who received prescriptions for amoxicillin or another antibiotic. Compared with individuals who took no antibiotics, those who took azithromycin had an increased risk of cardiovascular death (hazard ratio, 2.88; 95% CI, 1.79-4.63). Individuals who took a 5-day course of azithromycin were also at elevated risk compared with those who took amoxicillin (hazard ratio, 2.49; 95% CI, 1.38-4.50). The authors estimate this would result in an additional 47 cardiovascular-related deaths per 1 million courses of azithromycin. They also said that the potential harm is even greater among patients who were already at elevated risk of cardiovascular adverse events, with azithromycin use associated with an estimated 245 cardiovascular deaths among such at-risk individuals.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview




Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles